Cargando…

The roles of gut microbiota and its metabolites in diabetic nephropathy

Diabetic nephropathy (DN) is a severe microvascular complication of diabetes, which increases the risk of renal failure and causes a high global disease burden. Due to the lack of sustainable treatment, DN has become the primary cause of end-stage renal disease worldwide. Gut microbiota and its meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hui, Yang, Cheng-E, Liu, Tian, Zhang, Ming-Xia, Niu, Yan, Wang, Ming, Yu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413983/
https://www.ncbi.nlm.nih.gov/pubmed/37577423
http://dx.doi.org/10.3389/fmicb.2023.1207132
_version_ 1785087249141989376
author Zhao, Hui
Yang, Cheng-E
Liu, Tian
Zhang, Ming-Xia
Niu, Yan
Wang, Ming
Yu, Jun
author_facet Zhao, Hui
Yang, Cheng-E
Liu, Tian
Zhang, Ming-Xia
Niu, Yan
Wang, Ming
Yu, Jun
author_sort Zhao, Hui
collection PubMed
description Diabetic nephropathy (DN) is a severe microvascular complication of diabetes, which increases the risk of renal failure and causes a high global disease burden. Due to the lack of sustainable treatment, DN has become the primary cause of end-stage renal disease worldwide. Gut microbiota and its metabolites exert critical regulatory functions in maintaining host health and are associated with many pathogenesis of aging-related chronic diseases. Currently, the theory gut–kidney axis has opened a novel angle to understand the relationship between gut microbiota and multiple kidney diseases. In recent years, accumulating evidence has revealed that the gut microbiota and their metabolites play an essential role in the pathophysiologic processes of DN through the gut–kidney axis. In this review, we summarize the current investigations of gut microbiota and microbial metabolites involvement in the progression of DN, and further discuss the potential gut microbiota-targeted therapeutic approaches for DN.
format Online
Article
Text
id pubmed-10413983
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104139832023-08-11 The roles of gut microbiota and its metabolites in diabetic nephropathy Zhao, Hui Yang, Cheng-E Liu, Tian Zhang, Ming-Xia Niu, Yan Wang, Ming Yu, Jun Front Microbiol Microbiology Diabetic nephropathy (DN) is a severe microvascular complication of diabetes, which increases the risk of renal failure and causes a high global disease burden. Due to the lack of sustainable treatment, DN has become the primary cause of end-stage renal disease worldwide. Gut microbiota and its metabolites exert critical regulatory functions in maintaining host health and are associated with many pathogenesis of aging-related chronic diseases. Currently, the theory gut–kidney axis has opened a novel angle to understand the relationship between gut microbiota and multiple kidney diseases. In recent years, accumulating evidence has revealed that the gut microbiota and their metabolites play an essential role in the pathophysiologic processes of DN through the gut–kidney axis. In this review, we summarize the current investigations of gut microbiota and microbial metabolites involvement in the progression of DN, and further discuss the potential gut microbiota-targeted therapeutic approaches for DN. Frontiers Media S.A. 2023-07-27 /pmc/articles/PMC10413983/ /pubmed/37577423 http://dx.doi.org/10.3389/fmicb.2023.1207132 Text en Copyright © 2023 Zhao, Yang, Liu, Zhang, Niu, Wang and Yu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Zhao, Hui
Yang, Cheng-E
Liu, Tian
Zhang, Ming-Xia
Niu, Yan
Wang, Ming
Yu, Jun
The roles of gut microbiota and its metabolites in diabetic nephropathy
title The roles of gut microbiota and its metabolites in diabetic nephropathy
title_full The roles of gut microbiota and its metabolites in diabetic nephropathy
title_fullStr The roles of gut microbiota and its metabolites in diabetic nephropathy
title_full_unstemmed The roles of gut microbiota and its metabolites in diabetic nephropathy
title_short The roles of gut microbiota and its metabolites in diabetic nephropathy
title_sort roles of gut microbiota and its metabolites in diabetic nephropathy
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413983/
https://www.ncbi.nlm.nih.gov/pubmed/37577423
http://dx.doi.org/10.3389/fmicb.2023.1207132
work_keys_str_mv AT zhaohui therolesofgutmicrobiotaanditsmetabolitesindiabeticnephropathy
AT yangchenge therolesofgutmicrobiotaanditsmetabolitesindiabeticnephropathy
AT liutian therolesofgutmicrobiotaanditsmetabolitesindiabeticnephropathy
AT zhangmingxia therolesofgutmicrobiotaanditsmetabolitesindiabeticnephropathy
AT niuyan therolesofgutmicrobiotaanditsmetabolitesindiabeticnephropathy
AT wangming therolesofgutmicrobiotaanditsmetabolitesindiabeticnephropathy
AT yujun therolesofgutmicrobiotaanditsmetabolitesindiabeticnephropathy
AT zhaohui rolesofgutmicrobiotaanditsmetabolitesindiabeticnephropathy
AT yangchenge rolesofgutmicrobiotaanditsmetabolitesindiabeticnephropathy
AT liutian rolesofgutmicrobiotaanditsmetabolitesindiabeticnephropathy
AT zhangmingxia rolesofgutmicrobiotaanditsmetabolitesindiabeticnephropathy
AT niuyan rolesofgutmicrobiotaanditsmetabolitesindiabeticnephropathy
AT wangming rolesofgutmicrobiotaanditsmetabolitesindiabeticnephropathy
AT yujun rolesofgutmicrobiotaanditsmetabolitesindiabeticnephropathy